Furthermore, varying degrees of tumoricidal impact are shown by CAR-T cells engineered to target the glycosylated C-terminal (487–598) or N-terminal (296–390) parts of MSLN, emphasizing the vital function of MSLN glycosylation has in regulating T-cell recognition and tumor suppression [2]. Here, MSLN is linked to neoplasm.